INTRODUCTION

1.1
Controlled drug delivery-The controlled drug delivery systems have been introduced to overwhelm the drawback of fluctuating drug levels associated with conventional dosage forms. The concept of sustained or prolonged release of biologically active agents has been well appreciated and randomized for decades. Basically there are three basic modes of drug delivery, i.e. targeted delivery, controlled release and modulated release. Controlled release refers to the use of a delivery device with the objective of releasing the drug into the patient body at a predetermined rate, or at specific times or with specific release profiles 1 .
1.1.1
Background of controlled drug delivery -lipid nanoemulsions were introduced during the 50's for the purpose of parenteral nutrition where 10-20% of total amount of fatty vegetable oils (e.g. soy oil) or middle chain triglycerides in emulsion as a lipid content were used and other ingredients were Phospholipids (stabilizer-0.6-1.5 %) and glycerol (osmorality-regulation, 2.25%) were added. During recent years more lipophilic formulations were commercialized e.g. etomidate (Etomidat-Lipuro ® ) and Diazepam (Diazepam-Lipuro ® ) 2, 3 . In the beginning of 80's, Speiser and coworkers developed solid lipid nanoparticles (by spray drying) and Nanopellets for peroral administration. The nanopellets developed by speiser were formulated by mixing melted lipids with high shear homogenizer but it was indicated that it was producing high quantity of microparticles as compared to nanoparticles. Then high pressure homogenization was developed, with this the 500 nm sized and low microparticles sized particles were characterized. 
1.1.2
Examples of colloidal particles are as follows:
1.1.2.1 DendrimersDendrimers are branched macromolecules in which each level of branching is classified as a generation. Generally, dendrimeric polymers developed for drug delivery have a multifunctional hydrophobic inner core that is conjugated to outer hydrophilic moieties, such as PEG. Dendrimeric polymers are promising drug delivery materials because they possess narrow polydispersity and can be designed with many combinations of size, shape, and surface chemistry. 1.1.2.3 Nanoemulsion-For a nanoemulsion formulation to include stable particles of a desired size, the interactions between the core-and shell-forming materials often require optimization. This can be done by experimentally by selecting compatible components and determining the appropriate mixing ratio. 
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The solid lipid nanopaticles are the colloidal drug delivery system which is spherical in shape and present in 10-1000nm particle sized range. The surfactant is used to stabilize the solid lipid nanoparticles to avoid aggregation. The Co-surfactant was used in addition to increase the micelles concentration. The optimization of surfactant concentration was used to stabilize the nanoparticles and microparticles formed and to decrease the particle size by decrease the aggregation. The manufacturing methods of the SLN are of four types, the high pressure homogenization which is further divides into two types hot homogenization method and cold homogenization method, Solvent-Diffusion evaporation method, ultrasonication method, and membrane contactor method. The non-uniform particles sizes were obtained from high pressure and ultra-sonication methods but the solvent-Diffusion Evaporation method and membrane contactor methods give uniform sized particles. But disadvantages of the later methods are the toxicity of organic solvent if not evaporates completely from the SLNs and the high cost of membrane contactor instrument is there in the formulation of SLNs. While the ultra-turrax and high pressure homogenization methods are the safest methods to use as compared to Solvent-Diffusion Evaporation method. The unpublished results have indicated that the drug release from the HPH and ultrasonication gave highest drug release as compared to marketed conventional gel and formulation obtained by Solvent-Diffusion Evaporation method. Keywords: SLN, high pressure homogenization method, Solvent-Diffusion Evaporation method, ultrasonication method, Membrane contactor method engineering. Polymeric micelles comprise a hydrophobic core, which can load and store drugs as cargo, and a hydrophilic shell, which surrounds and solubilizes the hydrophobic core and hinders interactions with components of the host mononuclear phagocytic system. 5 1.1.2.5 Micelles formed from star-shaped block copolymers-Unimolecular micelles are inherently stable to dilution and may be prepared to be monodisperse and of a smaller size than most multimolecular systems. Star shaped block co-polymers are an excellent material for making unimolecular micelles, provided the molecules can be engineered to avoid self aggregation 5 1.1.2.6 Solid lipid NanoparticlesSolid lipid nanoparticles are the nano-carriers which remain solid at room temperature and changes into liquid form while melting at increasing temperature. SLN are composed of 0.1% (w/w) to 30% (w/w) solid lipid dispersed in an aqueous medium and if necessary stabilized with preferably 0.5% (w/w) to 5% (w/w) surfactant. The incorporation of cosmetic and pharmaceutical actives is feasible. The mean particle size of SLN is in the submicron rage, ranging from about 40 to 1000nm. In the second generation of the lipid nanoparticle technology, the particles are produced using blends of solid lipids and liquid lipids (oils). To obtain the blends for the particles matrix, solid lipids are mixed with liquid lipids (oils), preferably in a ratio of 70:30 upto a ratio of 99.9:0.1. The major advantage of SLN is the possibility of production on large industrial scale. However, depending on the drug some potential problems can occur, such as drug leakage during storage and insufficient total drug load. To overcome the limitations of SLN, nanostructured lipid carriers (NLC) have been developed. The later consists of a solid lipid matrix with a high content of liquid lipid. Formation of an almost perfect crystalline structure in SLN (left) by identically shaped molecules similar to a brick wall with limited loading capacity for actives. Formation of a solid particle matrix of NLC (right) with many imperfections comparable to building a wall from very differently shaped stones, the increased number of imperfections leads to an increased loading capacity for active compounds. Fig. 1.3 shows schematically the steps of these two methods. The active compound is dissolved or dispersed in melted solid lipid for SLN or in a mixture of liquid lipid (oil) and melted solid lipid for NLC. In the hot homogenization method the lipid melt containing the active compound is dispersed in a hot surfactant solution of the same temperature (5-10 •C above the melting point of the solid lipid or lipid blend) by high speed stirring. The obtained emulsion (generally called pre-emulsion) is then passed through a high pressure homogenizer adjusted to the same temperature generally applying three cycles at 500 bar or two cycles at 800 bars.
In the cold homogenization method, the active containing lipid melt is cooled down. After solidification the mass is crushed and ground to obtain lipid microparticles. The lipid microparticles are then dispersed in a cold surfactant solution yielding a cold pre-suspension of micronized lipid particles. This suspension is passed through a high pressure homogenizer at room temperature applying typically 5-10 cycles at 1500 bar. Addition of SLN or NLC to an existing product, e.g. cream or lotion, is realized by replacing a part of the water phase with concentrated SLN or NLC dispersion. To maintain the lipid content of the original cream or lotion, the lipid content of the original formulation can be reduced about the amount of incorporated lipid from the lipid nanoparticles. The creams and lotions are produced using the established way of production, cooled to about 30 •C, and the concentrated lipid nanoparticles suspension is then admixed applying gentle stirring. Instabilities of lipid nanoparticles in cosmetic or pharmaceutical creams or lotions containing oil droplets that might occur are aggregation or dissolution. The presence of solid lipid in such formulations can be proven by differential scanning calorimetry (DSC). The particle size can be determined using photon correlation spectroscopy (PCS) or laser diffractometry (LD). Hydrogel formulations (xanthan gum, hydroxyethylcellulose 4000, Carbopol 943 and chitosan) containing SLN or NLC were investigated regarding the physical stability of the lipid nanoparticles. For both lipid nanocarriers a good physical stability was reported. Using high lipid concentrations a final product can be produced in one step. These particle dispersions have a relatively high consistency; they are cream like or almost solid. By PCS, LD and electron microscopy the existence of intact particles can be proven. 6 In the un-published results of experiment with insoluble drug, the 4 microns sized particles are obtained but was non-uniform sized. 1.2.6.4.1 Influence of the emulsifier in SLN Formulation-High concentrations of the emulsifier reduce the surface tension and facilitate the particle partition used during homogenization. The decrease in particle size is connected with a tremendous increase in surface. The increase of the surface area during HPH occurs very rapidly. Therefore, kinetic aspects have to be considered. The process of a primary coverage of the new surfaces competes with the agglomeration of uncovered lipid surfaces. The primary dispersion must contain excessive emulsifier molecules, which should rapidly cover the new surfaces.
Influence of the lipids concentration in SLN
Formulation-Using the hot homogenization, it has been found that the average particle size of SLN dispersions is increasing with higher melting lipids. These are in agreement to the general theory of HPH and can be explained by the higher viscosity of the dispersed phase. However, other critical parameters for nanoparticle formation will be different for the different lipids. Examples include the velocity of lipid crystallization, the lipid hydrophilicity (influence on self-emulsifying properties) and the shape of the lipid crystals (and therefore the surface area). It is also noteworthy, that most of the lipids used represent a mixture of several chemical com pounds. The composition might therefore vary from different suppliers and might even vary for different batches from the same supplier. However, small differences in the lipid composition (e.g. impurities) might have considerable impact on the quality of SLN dispersion (e.g. by changing the zeta potential, retarding crystallization processes etc). By increasing the lipid content over 5-10% results in larger particles (including micro particles) and broader particle size distributions. Both a decrease of the homogenization efficiency and an increase in particle agglomeration cause this phenomenon which has been observed for lipid nanoemulsions, too. 
CONCLUSION:
The all above formulation methods having many advantages and disadvantages but the high drug release is obtained from the high pressure homogenization of SLN-NLC type formulation. The nonuniformity of the SLNs is there in ultra-sonication method.
